Sirachainan Nongnuch, Chuansumrit Ampaiwan, Sasanakul Werasak, Yudhasompop Najwa, Mahaklan Lalita, Vaewpanich Jarin, Charoenkwan Pimlak, Kanjanapongkul Somjai, Visudtibhan Anannit, Wongwerawattanakoon Pakawan
1 Faculty of Medicine, Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
2 Department of Pediatrics, Hatyai Hospital, Hatyai, Songkhla, Thailand.
Clin Appl Thromb Hemost. 2018 Mar;24(2):263-267. doi: 10.1177/1076029617709085. Epub 2017 May 17.
The p.R147W mutation, the c.C6152T in exon 7, causing a change in amino acid from arginine to tryptophan of the PROC gene has been reported as a common mutation in Taiwanese populations with venous thromboembolism (VTE). The present study aimed to identify the prevalence of p.R147W in the Thai population and children with TE and the risk of developing TE. Patients aged ≤18 years diagnosed with TE were enrolled. The PROC gene was amplified by polymerase chain reaction using a specific primer in exon 7. The restriction fragment length polymorphism was designed using MwoI restriction enzyme. A total of 184 patients and 690 controls were enrolled. The most common diagnosis of TE was arterial ischemic stroke (AIS), at 100 (54.3%), followed by VTE, at 38 (20.6%), and cerebral venous sinus thrombosis (CVST), at 23 (12.5%). The prevalence of heterozygous and homozygous p.R147W in patients and controls was 9.5% versus 5.8% and 2.7% versus 0.1%, respectively. Heterozygous p.R147W had odds ratios (ORs) of 1.8 (95% confidence interval [CI]: 1.0-3.2, P = .04), 3.2 (95% CI: 1.2-8.2, P = .009), and 4.5 (95% CI: 1.6-12.8, P = .002) of developing overall TE, VTE, and CVST, respectively. Homozygous p.R147W had ORs of 20.2 (95% CI: 2.3-173.7, P < .001), 21.4 (95% CI: 2.2-207.9, P < .001), and 43.3 (95% CI: 3.8-490.6, P < .001) of developing overall TE, AIS, and CVST, respectively. This study suggested that p.R147W is a common mutation and increased risk of TE in Thai children.
PROC基因第7外显子中的c.C6152T突变导致氨基酸从精氨酸变为色氨酸,即p.R147W突变,据报道这是台湾静脉血栓栓塞症(VTE)人群中的常见突变。本研究旨在确定泰国人群和血栓栓塞症(TE)患儿中p.R147W的患病率以及发生TE的风险。纳入年龄≤18岁且诊断为TE的患者。使用第7外显子的特异性引物通过聚合酶链反应扩增PROC基因。使用MwoI限制酶设计限制性片段长度多态性。共纳入184例患者和690例对照。TE最常见的诊断是动脉缺血性卒中(AIS),共100例(54.3%),其次是VTE,共38例(20.6%),以及脑静脉窦血栓形成(CVST),共23例(12.5%)。患者和对照中杂合子和纯合子p.R147W的患病率分别为9.5%对5.8%和2.7%对0.1%。杂合子p.R147W发生总体TE、VTE和CVST的比值比(OR)分别为1.8(95%置信区间[CI]:1.0 - 3.2,P = 0.04)、3.2(95% CI:1.2 - 8.2,P = 0.009)和4.5(95% CI:1.6 - 12.8,P = 0.002)。纯合子p.R147W发生总体TE、AIS和CVST的OR分别为20.2(95% CI:2.3 - 173.7,P < 0.001)、21.4(95% CI:2.2 - 207.9,P < 0.001)和43.3(95% CI:3.8 - 490.6,P < 0.001)。本研究表明,p.R147W是泰国儿童中常见的突变,且会增加TE的风险。